Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001121781-10-000418
Filing Date
2010-11-23
Accepted
2010-11-23 15:37:47
Documents
1
Period of Report
2010-11-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3155
  Complete submission text file 0001121781-10-000418.txt   5183
Mailing Address 23RD FLOOR, UNIONSUN YANGKUO PLAZA NO.2, BLOCK 3, RENMIN ROAD SOUTH CHENGDU, P.R. F4 610041
Business Address 23RD FLOOR, UNIONSUN YANGKUO PLAZA NO.2, BLOCK 3, RENMIN ROAD SOUTH CHENGDU, P.R. F4 610041 0086-028-86154737
TIANYIN PHARMACEUTICAL CO., INC. (Issuer) CIK: 0001362718 (see all company filings)

EIN.: 204857782 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address UNIT 06, 21/F, BEAUTIFUL GROUP TOWER 77 CONNAUGHT ROAD CENTRAL, HONG KONG, CHENGDU F4 610041
Business Address
TONG JAMES JIAYUAN (Reporting) CIK: 0001489785 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34189 | Film No.: 101211730